Tymissha Jackson

Tymissha Jackson, MS, RAC, currently serves as the Head of US Regulatory Affairs at Immatics, a position held since August 2024. Previously, Tymissha was the Senior Director of Regulatory Affairs at Allogene Therapeutics from August 2022 to July 2024 and held similar senior director roles at Castle Creek Biosciences, Inc. and Adaptimmune, focusing on regulatory affairs in cell and gene therapy and oncology. Tymissha's extensive regulatory experience includes strategic leadership at GSK, where responsibilities spanned early and late-stage clinical developments across various therapeutic areas. Tymissha's academic background includes a BS in Biology from the University of North Carolina at Chapel Hill and an MS in Molecular Biology from North Carolina Central University.